Mineralocorticoid receptor, coronary microvascular function, and cardiac efficiency in hypertension
盐皮质激素受体、冠状动脉微血管功能和高血压患者的心脏效率
基本信息
- 批准号:10586784
- 负责人:
- 金额:$ 77.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-01 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAftercareAlbuminuriaAldosteroneAngiotensin ReceptorAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsBlood PressureBlood Pressure MonitorsBlood VesselsBlood flowCardiacCardiovascular systemChlorthalidoneChronicClinicalClinical ResearchCoronaryCouplingDiureticsEchocardiographyEnalaprilEnzyme InhibitionFoundationsFunctional disorderGoalsGuidelinesHeartHeart AbnormalitiesHeart DiseasesHumanHypertensionImpairmentIndividualKnowledgeLeft Ventricular HypertrophyMicrovascular DysfunctionMineralocorticoid ReceptorMorbidity - disease rateMyocardialNon-Insulin-Dependent Diabetes MellitusOutcomeOxygenOxygen ConsumptionPET/CT scanParticipantPatientsPeptidyl-Dipeptidase APlacebosPositron-Emission TomographyPotassiumProcessRandomizedRecommendationRelaxationRestRiskRisk FactorsRoleStressStructureTestingTissuesWomanWorkantagonistcardiovascular risk factoreplerenoneexperimental studyheart functionhypertension treatmenthypertensiveimprovedmechanical energymenmortalitypreventprimary outcomereceptorrecruitthiazidevascular abnormality
项目摘要
ABSTRACT
Hypertension is a major risk factor for cardiovascular (CV) morbidity and mortality. Increased CV risk remains
even if blood pressure (BP) is controlled, suggesting there are additional factors associated with hypertension
(influenced by, but independent of, BP per se), which contribute to adverse CV outcomes. This application
focuses on two potentially interrelated CV pathophysiologic processes: 1) impairment in myocardial oxygen
delivery (manifested as coronary microvascular dysfunction, a known predictor of CV morbidity/mortality) and 2)
impairment in cardiac efficiency (manifested as inefficient coupling of myocardial oxygen consumption and
cardiac work). There are no established treatments for coronary microvascular dysfunction or abnormal
cardiac efficiency—a critical knowledge gap. Individuals with hypertension and left ventricular hypertrophy
(LVH) have coronary microvascular dysfunction and excess mineralocorticoid receptor activity. Our overall
hypothesis is that, in individuals with hypertension and LVH, mineralocorticoid receptor blockade will improve
coronary microvascular function and cardiac efficiency, independent of changes in BP; and these improvements
will lead to improved myocardial structure and function and ultimately to improved CV outcomes.
We propose a randomized, controlled, basic experimental study involving humans. Men and women with
hypertension and LVH on enalapril (angiotensin-converting enzyme (ACE) inhibitor) will be randomized to
treatment for 9 months with eplerenone (mineralocorticoid receptor antagonist) or chlorthalidone (thiazide-like
diuretic) + potassium. We will use cardiac PET/CT to quantify changes in coronary microvascular function (i.e.
myocardial flow reserve - ratio of stress/rest myocardial blood flow) and cardiac efficiency (i.e. myocardial
external efficiency - ratio of myocardial work to oxygen consumption); echocardiography to assess changes in
myocardial structure and function; and 24-hr BP monitoring.
This study will test the hypothesis that, in patients with hypertension and LVH on ACE inhibition,
treatment with mineralocorticoid receptor antagonist, as compared with a thiazide-like diuretic,
improves:
• Coronary microvascular function, i.e., myocardial flow reserve (Specific Aim 1)
• Cardiac efficiency, i.e., myocardial external efficiency (Specific Aim 2)
We anticipate that improvements in these outcomes will associate with improvements in myocardial structure
and function (peak global longitudinal strain, tissue Doppler mitral annular early diastolic relaxation velocity [e’],
and ratio of mitral E velocity to e’ [E/e’]).
摘要
高血压是心血管(CV)发病率和死亡率的主要风险因素。CV风险增加
即使血压(BP)得到控制,这表明还有其他因素与高血压相关
(受BP本身的影响,但独立于BP本身),这会导致不良CV结局。本申请
重点关注两个潜在相关的CV病理生理过程:1)心肌氧损伤
分娩(表现为冠状动脉微血管功能障碍,CV发病率/死亡率的已知预测因素)和2)
心脏效率的损害(表现为心肌耗氧量的无效偶联,
心脏工作)。对于冠状动脉微血管功能障碍或异常,
心脏效率-一个关键的知识缺口。高血压和左心室肥厚患者
(LVH)冠状动脉微血管功能障碍和盐皮质激素受体活性过剩。我们的整体
假设在高血压和LVH患者中,盐皮质激素受体阻滞剂将改善
冠状动脉微血管功能和心脏效率,独立于血压的变化;这些改善
将改善心肌结构和功能,并最终改善CV结局。
我们提出了一个随机的,对照的,基本的实验研究涉及人类。男性和女性
接受依那普利(血管紧张素转换酶(ACE)抑制剂)治疗的高血压和LVH患者将被随机分配至
用依普利酮(盐皮质激素受体拮抗剂)或氯噻酮(噻嗪类)治疗9个月
利尿剂)+钾。我们将使用心脏PET/CT来量化冠状动脉微血管功能的变化(即,
心肌血流储备-应激/静息心肌血流的比率)和心脏效率(即心肌血流储备
外部效率-心肌功与耗氧量的比值);超声心动图评估
心肌结构和功能; 24小时血压监测。
本研究将检验以下假设:在高血压伴LVH患者中,
与噻嗪类利尿剂相比,
改善:
·冠状动脉微血管功能,即心肌血流储备(特定目标1)
·心脏效率,即,心肌外效率(特定目标2)
我们预期这些结果的改善将与心肌结构的改善相关
和功能(峰值整体纵向应变,组织多普勒二尖瓣环舒张早期舒张速度[e '],
和二尖瓣E流速与e'的比值[E/e'])。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gail Kurr Adler其他文献
Gail Kurr Adler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gail Kurr Adler', 18)}}的其他基金
The Functional Neuroanatomy of the Human Physiological Stress Response
人类生理应激反应的功能神经解剖学
- 批准号:
10609821 - 财政年份:2019
- 资助金额:
$ 77.85万 - 项目类别:
The functional neuroanatomy of the human physiological stress response
人类生理应激反应的功能神经解剖学
- 批准号:
9924682 - 财政年份:2019
- 资助金额:
$ 77.85万 - 项目类别:
The functional neuroanatomy of the human physiological stress response
人类生理应激反应的功能神经解剖学
- 批准号:
10394222 - 财政年份:2019
- 资助金额:
$ 77.85万 - 项目类别:
Aldosterone and Diabetic Cardiovascular Disease: Research and Mentoring Progam
醛固酮和糖尿病心血管疾病:研究和指导计划
- 批准号:
8261917 - 财政年份:2011
- 资助金额:
$ 77.85万 - 项目类别:
Aldosterone and Cardiovascular Disease: Research and Mentoring Program
醛固酮和心血管疾病:研究和指导计划
- 批准号:
9456791 - 财政年份:2011
- 资助金额:
$ 77.85万 - 项目类别:
Aldosterone and Diabetic Cardiovascular Disease: Research and Mentoring Progam
醛固酮和糖尿病心血管疾病:研究和指导计划
- 批准号:
8661245 - 财政年份:2011
- 资助金额:
$ 77.85万 - 项目类别:
Aldosterone and Cardiovascular Disease: Research and Mentoring Program
醛固酮和心血管疾病:研究和指导计划
- 批准号:
9314760 - 财政年份:2011
- 资助金额:
$ 77.85万 - 项目类别:
Aldosterone and Cardiovascular Disease: Research and Mentoring Program
醛固酮和心血管疾病:研究和指导计划
- 批准号:
10155549 - 财政年份:2011
- 资助金额:
$ 77.85万 - 项目类别:
Aldosterone and Diabetic Cardiovascular Disease: Research and Mentoring Progam
醛固酮和糖尿病心血管疾病:研究和指导计划
- 批准号:
8462676 - 财政年份:2011
- 资助金额:
$ 77.85万 - 项目类别:
Aldosterone and Diabetic Cardiovascular Disease: Research and Mentoring Progam
醛固酮和糖尿病心血管疾病:研究和指导计划
- 批准号:
8112135 - 财政年份:2011
- 资助金额:
$ 77.85万 - 项目类别:
相似海外基金
Life outside institutions: histories of mental health aftercare 1900 - 1960
机构外的生活:1900 - 1960 年心理健康善后护理的历史
- 批准号:
DP240100640 - 财政年份:2024
- 资助金额:
$ 77.85万 - 项目类别:
Discovery Projects
Development of a program to promote psychological independence support in the aftercare of children's homes
制定一项计划,促进儿童之家善后护理中的心理独立支持
- 批准号:
23K01889 - 财政年份:2023
- 资助金额:
$ 77.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
- 批准号:
10452217 - 财政年份:2022
- 资助金额:
$ 77.85万 - 项目类别:
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
- 批准号:
10670838 - 财政年份:2022
- 资助金额:
$ 77.85万 - 项目类别:
Aftercare for young people: A sociological study of resource opportunities
年轻人的善后护理:资源机会的社会学研究
- 批准号:
DP200100492 - 财政年份:2020
- 资助金额:
$ 77.85万 - 项目类别:
Discovery Projects
Creating a National Aftercare Strategy for Survivors of Pediatric Cancer
为小儿癌症幸存者制定国家善后护理策略
- 批准号:
407264 - 财政年份:2019
- 资助金额:
$ 77.85万 - 项目类别:
Operating Grants
Aftercare of green infrastructure: creating algorithm for resolving human-bird conflicts
绿色基础设施的善后工作:创建解决人鸟冲突的算法
- 批准号:
18K18240 - 财政年份:2018
- 资助金额:
$ 77.85万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an aftercare model for children who have experienced invasive procedures
为经历过侵入性手术的儿童开发善后护理模型
- 批准号:
17K12379 - 财政年份:2017
- 资助金额:
$ 77.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a Comprehensive Aftercare Program for children's self-reliance support facility
为儿童自力更生支持设施制定综合善后护理计划
- 批准号:
17K13937 - 财政年份:2017
- 资助金额:
$ 77.85万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Project#2 Extending Treatment Effects Through an Adaptive Aftercare Intervention
项目
- 批准号:
8742767 - 财政年份:2014
- 资助金额:
$ 77.85万 - 项目类别: